Form: 8-K

Current report filing

August 4, 2015





EXHIBIT 99.1

PRESS RELEASE

EMCORE Corporation Announces Financial Results for Third Quarter Ended June 30, 2015

Generates Net Income from Continuing Operations

Consolidated Q3 revenue of $21.2 million
Non-GAAP Q3 income from continuing operations of $1.3 million and GAAP income from continuing operations of $0.5 million
Consolidated Q3 GAAP net income of $2.4 million after taking into effect income from discontinued operations of $2.0 million
Anticipate Q4 revenue of $22 to $24 million for the remaining Broadband Fiber Optics business
Completed a modified "Dutch auction" and tender offer and purchased $45.0 million shares of our common stock in June


ALHAMBRA, California, August 4, 2015 - EMCORE Corporation (NASDAQ: EMKR - News), a leading provider of compound semiconductor-based components, subsystems, and systems for the broadband and specialty fiber optics market, today announced financial results for its third quarter ended June 30, 2015.

Financial Highlights - Third Quarter Ended June 30, 2015

Financial Highlights
 
For the Three Months Ended
(in thousands)
 
June 30, 2015
 
March 31, 2015
 
June 30, 2014
Revenue
 
$
21,194

 
$
19,057

 
$
13,596

Gross Profit
 
$
7,683

 
$
6,379

 
$
2,659

Operating income (loss)
 
$
866

 
$
(1,597
)
 
$
(5,045
)
Income (loss) from continuing operations - Non-GAAP
 
$
1,299

 
$
13

 
$
(4,140
)



Financial Statement Highlights for the Third Quarter of Fiscal 2015:
Consolidated revenue was $21.2 million, representing a 11.2% increase from the immediate preceding quarter
Consolidated gross margin was 36.3%, an improvement from the 33.5% gross margin reported in the immediate preceding quarter
Non-GAAP income from continuing operations was $1.3 million, an improvement of approximately $1.3 million over the immediate preceding quarter






Income from discontinued operations, net of tax, of $2.0 million
Consolidated net income was $2.4 million, a $0.6 million decrease when compared to the immediate preceding quarter
Consolidated net income per share was $0.08 compared to net income per share of $0.10 in the immediate preceding quarter
Cash and cash equivalents was $114.1 million at the end of the third quarter.

"This quarter's performance marks three important financial milestones for EMCORE; a return to GAAP profitability from continuing operations, stronger non-GAAP net income and generation of positive cash flows from operations," said Jeffrey Rittichier, EMCORE's President and Chief Executive Officer. "In addition to top line growth across our major product lines, we are also beginning to realize the benefits of improved performance in operations from our lean manufacturing initiatives. We see our third quarter's performance as a significant step forward for our shareholders."

Business Outlook
We expect revenue for the fourth quarter ended September 30, 2015 to be in the range of $22 to $24 million.

Modified "Dutch Auction" Tender Offer
On May 15, 2015, we announced the commencement of a modified "Dutch auction" tender offer to purchase for cash shares of our common stock (the "Tender Offer"). On June 15, 2015, we completed the Tender Offer and purchased 6.9 million shares of our common stock at a purchase price of $6.55 per share, for a total aggregate cost of $45.0 million, excluding fees and expenses related to the tender offer.

Conference Call
We will discuss our financial results today at 4:30 p.m. ET. The call will be webcast via the Company's website at http://www.emcore.com. Please go to the site beforehand to download any necessary software. A webcast will be available for replay beginning August 4, 2015 following the conclusion of the call on the Company's website.

About EMCORE
EMCORE Corporation offers a broad portfolio of compound semiconductor-based products for the broadband and specialty fiber optics market. EMCORE provides optical components, subsystems and systems for Cable Television (CATV) and Fiber-To-The-Premise (FTTP) networks, as well as products for satellite communications, video transport and specialty photonics technologies for defense and homeland security applications. For further information about EMCORE, visit http://www.emcore.com.


Use of Non-GAAP Financial Measures
We disclose non-GAAP net income (loss) from continuing operations as a supplemental measure to U.S. GAAP income (loss) from continuing operations regarding our operational performance. This financial measure excludes the impact of certain items that we do not believe are indicative of our core operating results; therefore, it has not been calculated in accordance with U.S. GAAP.

We believe that this additional non-GAAP financial measure is useful to investors in assessing our operating performance. We also use this financial measure internally to evaluate our operating performance and for planning and forecasting of future periods. In addition, financial analysts that follow us may focus on and publish both historical results and future projections based on our non-GAAP financial measure. We also believe that it is in the best interest of our investors to provide this non-GAAP information.

While we believe that this non-GAAP financial measure provides useful supplemental information to investors, there are limitations associated with the use of this non-GAAP financial measure. Our non-GAAP financial measure may not be reported by all of our competitors and it may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using this non-GAAP financial measure as a supplement to U.S. GAAP and by providing a reconciliation of our non-GAAP financial measure to its most comparable U.S. GAAP financial measure.

Non-GAAP financial measures are not in accordance with or an alternative for U.S. GAAP. Our non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable U.S. GAAP financial measures and it should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP.






Forward-Looking Statements
The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, projections about our future results included in our Exchange Act reports, statements about our plans, strategies, business prospects, changes and trends in our business and the markets in which we operate.

These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, enhancements or technologies, sales levels, expense levels and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.

These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) the rapidly evolving markets for the Company's products and uncertainty regarding the development of these markets; (b) the Company's historical dependence on sales to a limited number of customers and fluctuations in the mix of products and customers in any period; (c) delays and other difficulties in commercializing new products; (d) the failure of new products: (i) to perform as expected without material defects, (ii) to be manufactured at acceptable volumes, yields, and cost, (iii) to be qualified and accepted by our customers, and, (iv) to successfully compete with products offered by our competitors; (e) uncertainties concerning the availability and cost of commodity materials and specialized product components that we do not make internally; (f) actions by competitors; and (g) other risks and uncertainties discussed under Item 1A - Risk Factors in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014, as updated by our subsequent periodic reports.
 
Neither management nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the SEC that are available on the SEC's web site located at www.sec.gov, including the sections entitled "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Certain information included in this press release may supersede or supplement forward-looking statements in our other Exchange Act reports filed with the SEC. We assume no obligation to update any forward-looking statement to conform such statements to actual results or to changes in our expectations, except as required by applicable law or regulation.







EMCORE CORPORATION
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)

 
 
 
For the Three Months Ended
 
For the Nine Months Ended
 
 
June 30, 2015
 
March 31, 2015
 
June 30, 2014
 
June 30, 2015
 
June 30, 2014
Revenue
 
$
21,194

 
$
19,057

 
$
13,596

 
$
58,667

 
$
41,212

Cost of revenue
 
13,511

 
12,678

 
10,937

 
39,426

 
33,264

Gross profit
 
7,683

 
6,379

 
2,659

 
19,241

 
7,948

Operating expense:
 
 
 
 
 
 
 
 
 
 
Selling, general, and administrative
 
4,543

 
5,954

 
5,364

 
19,124

 
15,348

Research and development
 
2,274

 
2,022

 
2,340

 
6,470

 
6,840

Gain from change in estimate on ARO obligation
 

 

 

 
(845
)
 

Loss on sale of assets
 

 

 

 
228

 

Total operating expense
 
6,817

 
7,976

 
7,704

 
24,977

 
22,188

Operating income (loss)
 
866

 
(1,597
)
 
(5,045
)
 
(5,736
)
 
(14,240
)
Other income (expense):
 
 
 
 
 
 
 
 
 
 
Interest income (expense), net
 
4

 
165

 
(134
)
 
39

 
(377
)
Foreign exchange gain (loss)
 
50

 
(6
)
 
(12
)
 
101

 
(2
)
Gain on sale of investment
 

 

 

 

 
307

Change in fair value of financial instruments
 

 
86

 
110

 
122

 
39

Total other income (expense)
 
54

 
245

 
(36
)
 
262

 
(33
)
Income (loss) from continuing operations before income tax (expense) benefit
 
920

 
(1,352
)
 
(5,081
)
 
(5,474
)
 
(14,273
)
Income tax (expense) benefit
 
(456
)
 
396

 
732

 
1,852

 
1,379

Income (loss) from continuing operations
 
464

 
(956
)
 
(4,349
)
 
(3,622
)
 
(12,894
)
Income from discontinued operations, net of tax
 
1,976

 
4,008

 
1,199

 
65,242

 
2,258

Net income (loss)
 
$
2,440

 
$
3,052

 
$
(3,150
)
 
$
61,620

 
$
(10,636
)
Per share data:
 
 
 
 
 
 
 
 
 
 
Net income (loss) per basic share:
 
 
 
 
 
 
 
 
 
 
   Continuing operations
 
$
0.02

 
$
(0.03
)
 
$
(0.14
)
 
$
(0.11
)
 
$
(0.42
)
   Discontinued operations
 
0.06

 
0.13

 
0.04

 
2.07

 
0.07

Net income (loss) per basic share
 
$
0.08

 
$
0.10

 
$
(0.10
)
 
$
1.96

 
$
(0.35
)
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) per diluted share:
 
 
 
 
 
 
 
 
 
 
   Continuing operations
 
$
0.02

 
$
(0.03
)
 
$
(0.14
)
 
$
(0.11
)
 
$
(0.42
)
   Discontinued operations
 
$
0.06

 
$
0.12

 
$
0.04

 
$
2.07

 
$
0.07

Net income (loss) per diluted share
 
$
0.08

 
$
0.09

 
$
(0.10
)
 
$
1.96

 
$
(0.35
)
 
 
 
 
 
 
 
 
 
 
 
Weighted-average number of basic shares outstanding
 
31,203

 
32,077

 
30,656

 
31,494

 
30,327

Weighted-average number of diluted shares outstanding
 
31,432

 
32,077

 
30,656

 
31,494

 
30,327







EMCORE CORPORATION
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
 
As of
 
As of
 
June 30,
2015
 
September 30,
2014
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
114,129

 
$
20,687

Restricted cash
26

 
1,482

Accounts receivable, net
14,083

 
12,769

Inventory
16,991

 
15,644

Deferred income taxes, net

 
3,908

Prepaid expenses and other current assets
5,808

 
5,336

Current assets of discontinued operations

 
44,065

Total current assets
151,037

 
103,891

Property, plant, and equipment, net
8,580

 
10,446

Other intangible assets, net
63

 
82

Deferred income taxes, net

 
20,172

Other non-current assets, net
311

 
512

Non-current assets of discontinued operations

 
56,239

Total assets
$
159,991

 
$
191,342

LIABILITIES and SHAREHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Borrowings from credit facility
$

 
$
26,518

Accounts payable
6,992

 
6,804

Deferred gain associated with sale of assets
3,400

 
3,400

Warrant liability

 
122

Accrued expenses and other current liabilities
14,274

 
15,209

Current liabilities of discontinued operations

 
20,924

Total current liabilities
24,666

 
72,977

Asset retirement obligations
1,753

 
4,543

Other long-term liabilities
71

 
755

Non-current liabilities of discontinued operations

 
720

Total liabilities
26,490

 
78,995

Shareholders’ equity:
 
 
 
Common stock
761,069

 
755,368

Treasury stock
(47,689
)
 
(2,071
)
Accumulated other comprehensive income
1,288

 
1,837

Accumulated deficit
(581,167
)
 
(642,787
)
Total shareholders’ equity
133,501

 
112,347

Total liabilities and shareholders’ equity
$
159,991

 
$
191,342









We have provided a reconciliation of our non-GAAP income (loss) from continuing operations financial measure to its most directly comparable U.S. GAAP financial measure as indicated in the table below:

EMCORE Corporation
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Income (Loss) from Continuing Operations
(in thousands, except per share data)
(unaudited)
 
 
For the Three Months Ended
 
For the Nine Months Ended
 
 
June 30,
2015
 
March 31, 2015
 
June 30,
2014
 
June 30,
2015
 
June 30,
2014
Income (loss) from continuing operations - US GAAP
 
$
464

 
$
(956
)
 
$
(4,349
)
 
$
(3,622
)
 
$
(12,894
)
Adjustments:
 
 
 
 
 
 
 
 
 
 
Amortization expense
 
6

 
6

 
6

 
18

 
18

Stock-based compensation expense
 
401

 
1,034

 
839

 
3,209

 
2,396

Income tax (benefit) expense
 
456

 
(396
)
 
(732
)
 
(1,852
)
 
(1,379
)
Accretion expense
 
22

 
52

 
43

 
90

 
128

Gain from change in estimate on ARO obligation
 

 

 

 
(845
)
 

Compensation expense associated with sale of Businesses
 

 
353

 

 
2,471

 

Specific severance and restructuring charges
 

 

 
151

 
965

 
697

Foreign exchange (gain) loss
 
(50
)
 
6

 
12

 
(101
)
 
2

Loss on sale of assets
 

 

 

 
228

 

Gain on sale of investment
 

 

 

 

 
(307
)
Change in fair value of financial instruments
 

 
(86
)
 
(110
)
 
(122
)
 
(39
)
Total adjustments
 
835

 
969

 
209

 
4,061

 
1,516

Income (loss) from continuing operations - Non-GAAP
 
$
1,299

 
$
13

 
$
(4,140
)
 
$
439

 
$
(11,378
)
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations - Non-GAAP per basic share
 
$
0.04

 
$
0.00

 
$
(0.14
)
 
$
0.01

 
$
(0.38
)
Income (loss) from continuing operations - Non-GAAP per diluted share
 
$
0.04

 
$
0.00

 
$
(0.14
)
 
$
0.01

 
$
(0.38
)
Weighted average number of basic shares outstanding
 
31,203

 
32,077

 
30,656

 
31,494

 
30,327

Weighted average number of diluted shares outstanding
 
31,432

 
32,077

 
30,656

 
31,494

 
30,327







Stock-based compensation expense
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense
For the Three Months Ended
 
For the Nine Months Ended
(in thousands)
June 30, 2015
 
March 31, 2015
 
June 30, 2014
 
June 30, 2015
 
June 30, 2014
Cost of revenue
$
88

 
$
81

 
$
121

 
$
273

 
$
347

Selling, general, and administrative
195

 
849

 
574

 
2,609

 
1,584

Research and development
118

 
104

 
144

 
327

 
465

Total stock-based compensation expense
$
401

 
$
1,034

 
$
839

 
$
3,209

 
$
2,396



Contact:
EMCORE Corporation
Mark Weinswig
(626) 293-3400
investor@emcore.com

TTC Group
Victor Allgeier
(646) 290-6400
vic@ttcominc.com

_________________________